C10orf90 and breast cancer: Based on the immunohistochemistry (IHC) score of the pathological tissue obtained from breast needle biopsy, 108 patients with breast cancer who underwent neoadjuvant chemotherapy were divided into two groups: those with high FATS expression and those with low FATS expression.